Back to Journals » Pediatric Health, Medicine and Therapeutics » Volume 5

Assessing the benefits and risks of tight glycemic control in critically ill children

Authors Kandil S, Faustino EV

Received 28 May 2014

Accepted for publication 27 June 2014

Published 25 August 2014 Volume 2014:5 Pages 93—98

DOI https://doi.org/10.2147/PHMT.S50410

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3


Sarah B Kandil, E Vincent Faustino

Department of Pediatrics, Division of Pediatric Critical Care, Yale University School of Medicine, New Haven, CT, USA

Abstract: The benefit of intravenous insulin for tight glycemic control (TGC) in critically ill patients is debatable. Initial single center trials on TGC in critically ill adults admitted to the surgical intensive care unit were promising and showed a decrease in mortality with TGC. However, subsequent multicenter trials were unable to replicate these findings, with one trial even showing increased mortality with TGC. In critically ill children, efficacy and safety of TGC is poorly understood. High rates of insulin-induced hypoglycemia with TGC are concerning. Currently, there are no recommendations on the use of TGC for critically ill children. This review summarizes the current literature on TGC in children, focusing on its benefits and risks.

Keywords: hyperglycemia, hypoglycemia, intensive care unit, insulin, glucose

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]